Tema ETFs LLC Buys New Holdings in Tango Therapeutics, Inc. $TNGXMarket Beat·1 day ago, 04:29 AMTNGX-0.19%
Tango Therapeutics ajukan program penjualan saham at-the-market hingga USD 400 jutaPUBT·2 days ago, 04:14 PMTNGX-0.19%
Tango Therapeutics | 8-K: FY2026 Q2 Revenue Meets Estimate at USD 0Earnings Watch·Aug 11 at 06:22 AMTNGX-0.19%
Tango Therapeutics Announces Executive Chair Transition | TNGX Stock NewsStockTitan·Aug 6 at 09:24 AMTNGX-0.19%
Tango Therapeutics President, R&D Crystal Adam disposes of USD 734,514 common sharesPUBT·Aug 5 at 03:02 PMTNGX-0.19%
DV Trading LLC Takes $6.29 Million Position in Tango Therapeutics, Inc. $TNGXMarket Beat·Aug 2 at 03:24 AMTNGX-0.19%GS-A-0.21%
Mizuho Securities Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)Tip Ranks·Jul 19 at 07:15 AMTNGX-0.19%
This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesdaybenzinga_article·Jul 15 at 05:59 AMTNGX-0.19%FISN+4.73%
Tango Therapeutics President, R&D Crystal Adam disposes of common shares worth $798,704PUBT·Jul 2 at 06:24 PMTNGX-0.19%
Tango Therapeutics director Robert Azelby files initial beneficial ownership statementPUBT·Jun 23 at 05:04 PMTNGX-0.19%
As AbbVie eyes Apogee, these biotech stocks earn the highest quant ratingsMSN·Jun 22 at 08:55 AMNTLA+0.68%LEGN+0.49%
Tango Therapeutics Prices $566.5 Million Equity Offering at $30 Per Share; 30-Day Option GrantedTradingView·Jun 10 at 04:23 PMTNGX-0.19%JPM-0.07%
